Sirolimus: A Successful Medical Treatment for Head and Neck Lymphatic Malformations
Lymphatic malformations are abnormalities that arise in the developing lymphatic system, most frequently presenting in the head and neck. They are typically treated with sclerotherapy, laser therapy, or surgery for localized lesions. Sirolimus, an inhibitor of the mammalian target of rapamycin, is a...
Main Authors: | Steven Curry, Andrew Logeman, Dwight Jones |
---|---|
Format: | Article |
Language: | English |
Published: |
Hindawi Limited
2019-01-01
|
Series: | Case Reports in Otolaryngology |
Online Access: | http://dx.doi.org/10.1155/2019/2076798 |
Similar Items
-
Refractory Head and Neck Lymphatic Malformation in Infants Treated With Sirolimus: A Case Series
by: Changhua Wu, et al.
Published: (2021-07-01) -
Efficacy of Sirolimus in Patients Requiring Tracheostomy for Life-Threatening Lymphatic Malformation of the Head and Neck: A Report From the European Reference Network
by: Annegret Holm, et al.
Published: (2021-09-01) -
Early Adjuvant Medication With the mTOR Inhibitor Sirolimus in a Preterm Neonate With Compressive Cystic Lymphatic Malformation
by: Marion Honnorat, et al.
Published: (2020-07-01) -
CHOICE OF TREATMENT OPTIONS FOR CYSTIC LYMPHATIC MALFORMATIONS IN THE HEAD AND NECK REGION: TREATMENT EXPERIENCE OF 81 CHILDREN
by: I. M. Benzar
Published: (2018-01-01) -
Lymphatic Malformation Responsive to Sirolimus in Keratinocytic Epidermal Nevus Syndrome with KRAS Mutation: A Case and Brief Literature Discussion
by: Emily Sideris, et al.
Published: (2021-04-01)